Analyst Commentary Reflects Cautious Optimism as Olin Faces Mixed Signals and Modest Valuation Gains

AN

AnalystConsensusTarget

AnalystConsensusTarget

Not Invested

Based on Analyst Price Targets

Published

30 Aug 24

Updated

22 Oct 25

n/a

n/a

AnalystConsensusTarget's Fair Value

n/a

1Y

-40.6%

7D

8.4%

Loading

1Y

-40.6%

7D

8.4%

You can edit this narrative until Oct 23 11:10 AM. Then, changes will post as Updates.

Author's Valuation

US$24.7310.3% undervalued

AnalystConsensusTarget Fair Value

Shared on 22 Oct 25

Fair value Increased 2.49%

Olin's analyst price target has increased from $24.13 to $24.73 per share, reflecting analysts' cautious optimism in light of mixed industry signals and recent adjustments in company forecasts. Analyst Commentary Analyst perspectives on Olin remain divided, with both bullish takeaways and areas of caution shaping recent research updates.

Shared on 08 Oct 25

Fair value Increased 2.84%

Olin's fair value estimate has increased modestly from $23.47 to $24.13 per share, as analysts revise expectations following lowered growth outlooks. They also note stabilization in key markets and the prospect of improving commercial sales performance.

Shared on 07 May 25

Fair value Decreased 14%

Shared on 30 Apr 25

Fair value Increased 0.74%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 23 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 17 Apr 25

Fair value Decreased 9.55%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 09 Apr 25

Fair value Decreased 4.68%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 02 Apr 25

Fair value Decreased 2.54%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 19 Mar 25

Fair value Increased 26%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 10 Mar 25

Fair value Increased 3.06%

AnalystConsensusTarget has increased profit margin from 5.5% to 6.2%, decreased future PE multiple from 8.9x to 7.7x and decreased shares outstanding growth rate from -0.0% to -0.0%.

AnalystConsensusTarget Fair Value

US$24.73

10.3% undervalued

Future estimation in

% p.a.

0

Decrease

Increase

Current revenue growth rate

2.46%

Chemicals revenue growth rate

0.62%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

%

0

Decrease

Increase

Current discount rate

9.90%

Calculation

US$337.59m

Earnings '28

x

10.49x

PE Ratio '28

=

US$3.54b

Market Cap '28

US$3.54b

Market Cap '28

/

108.97m

No. shares '28

=

US$32.50

Share Price '28

US$32.50 Share Price '28

Discounted to 2025 @ 9.86% p.a.

=

US$24.51

Fair Value '25